Dr. Jason Karlawish and Dr. Emily Largent offer their takes on using driving performance and credit scores to predict the onset of dementia. Should entities like auto insurance companies have access to test results of these predictors? Dr. Largent weighs in.
Archives for August 2021
Farewell to Melissa Johnston Esparza, clinical research coordinator
By Cait Kearney
Melissa Johnston Esparza is moving on from the Penn Memory Center (PMC) after three years as a clinical research coordinator.
“PMC is a wonderful organization, and having been a part of helping advance its mission has been a rewarding experience I will cherish forever,” Johnston Esparza said.
Johnston Esparza joined PMC as a clinical research coordinator for the REVEAL-SCAN Study (Risk Evaluation and Education of Alzheimer’s Disease: The Study of Communicating Amyloid Neuroimaging), a project investigating the impact of learning one’s personal risk of having Alzheimer’s disease on thinking and health behaviors.
“Melissa is a stellar coordinator. She stepped into a study that was in distress and quickly turned it around and into a great scientific success,” said Jason Karlawish, MD, co-director of PMC and co-principal investigator of the REVEAL-SCAN Study.
Recently Approved Alzheimer Drug Raises Questions That Might Never Be Answered — JAMA Network
In JAMA Network Medical News, Dr. Jason Karlawish expressed his concern that Aduhelm’s approval will have a negative impact on the enrollment of future clinical trials.